Get started
HARVEST FUND MANAGEMENT CSI VACCINE AND BIOTECHNOLOGY INDEX ETFHARVEST FUND MANAGEMENT CSI VACCINE AND BIOTECHNOLOGY INDEX ETFHARVEST FUND MANAGEMENT CSI VACCINE AND BIOTECHNOLOGY INDEX ETF

HARVEST FUND MANAGEMENT CSI VACCINE AND BIOTECHNOLOGY INDEX ETF

No trades
See on Supercharts
Overview
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪260.37 M‬ CNY
Fund flows (1Y)
‪−70.76 M‬ CNY
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.1%
Shares outstanding
‪406.89 M‬
Expense ratio
0.60%

About HARVEST FUND MANAGEMENT CSI VACCINE AND BIOTECHNOLOGY INDEX ETF


Issuer
Harvest Fund Management Co., Ltd.
Brand
Harvest Funds
Home page
jsfund.cn
Inception date
Feb 16, 2023
Structure
Open-Ended Fund
Index tracked
CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Harvest Fund Management Co., Ltd.
ISIN
CNE100005SV2
The fund conducts passive index investment, closely tracks the underlying index, pursues the minimization of tracking deviation and tracking err, and strives to have the absolute value of the daily average tracking deviation not exceed 0.2%, and the annualized tracking err not exceed 2%

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks98.68%
Health Technology84.44%
Process Industries4.08%
Producer Manufacturing3.46%
Transportation2.24%
Commercial Services2.06%
Retail Trade1.62%
Finance0.77%
Bonds, Cash & Other1.32%
Cash1.32%
Stock breakdown by region
3%96%
Asia96.90%
Europe3.10%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


562860 invests in stocks. The fund's major sectors are Health Technology, with 84.44% stocks, and Process Industries, with 4.08% of the basket. The assets are mostly located in the Asia region.
562860 top holdings are Chongqing Zhifei Biological Products Co., Ltd. Class A and Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A, occupying 10.26% and 8.72% of the portfolio correspondingly.
562860 assets under management is ‪260.37 M‬ CNY. It's fallen 1.32% over the last month.
562860 fund flows account for ‪−70.76 M‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 562860 doesn't pay dividends to its holders.
562860 shares are issued by Harvest Fund Management Co., Ltd. under the brand Harvest Funds. The ETF was launched on Feb 16, 2023, and its management style is Passive.
562860 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
562860 follows the CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
562860 invests in stocks.
562860 price has risen by 7.18% over the last month, and its yearly performance shows a 0.94% increase. See more dynamics on 562860 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 7.11% over the last month, showed a 3.69% increase in three-month performance and has increased by 0.28% in a year.
562860 trades at a premium (0.14%) meaning the ETF is trading at a higher price than the calculated NAV.